Mena FN

Prodeon Medical Receives FDA 510(K) Clearance For The Urocross® Expander System, A Novel Non-Permanent Retrievable Implant For Treating Urinary Symptoms Associated With Benign ...

(MENAFN- GlobeNewsWire - Nasdaq) The Urocross® Expander System is designed to remodel the obstructing prostatic lobes during the six-month indwell time and is intentionally retrieved, leaving no ...
The Hamilton Spectator

Prodeon Medical Receives FDA 510(k) Clearance for the Urocross® Expander System, a Novel Non-Permanent Retrievable Implant for Treating Urinary Symptoms Associated with Benign ...

SUNNYVALE, Calif., March 16, 2026 (GLOBE NEWSWIRE) — Prodeon Medical, a privately held medical device company focused on advancing minimally invasive therapies for urologic diseases, today announced ...